We Can Medicines Balance Sheet

Financials in millions TWD. Fiscal year is January - December.

Millions TWD. Fiscal year is Jan - Dec.

Fiscal Year	TTM	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020
Period Ending	Sep '25 Sep 30, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021	Dec '20 Dec 31, 2020
Cash & Equivalents	238.19	305.67	160.53	216.26	203.36	120.18
Trading Asset Securities	40.24	-	-	-	-	150
Cash & Short-Term Investments	278.43	305.67	160.53	216.26	203.36	270.18
Cash Growth	13.51%	90.42%	-25.77%	6.34%	-24.73%	-
Accounts Receivable	190.06	178.05	225.54	142	127.47	72.93
Other Receivables	40.1	40.75	40.05	27.98	26.08	14.31
Receivables	230.16	218.8	265.59	169.98	153.55	87.24
Inventory	838.16	850.88	776.83	690.45	583.97	529.88
Prepaid Expenses	86.34	87.82	87.96	75.79	52.49	50.13
Other Current Assets	0.98	1.45	0.63	2.16	1.55	1.08
Total Current Assets	1,434	1,465	1,292	1,155	994.92	938.51
Property, Plant & Equipment	1,528	1,562	1,515	1,370	1,150	764.48
Other Intangible Assets	4.48	6.95	3.87	4.97	9.38	10.15
Long-Term Deferred Tax Assets	0.53	0.53	0.6	1.19	16.82	16.82
Other Long-Term Assets	51.33	51.38	50.22	44.9	39.13	36.27
Total Assets	3,019	3,086	2,861	2,576	2,210	1,766
Accounts Payable	500.41	507.36	540.01	517.49	443.55	291.34
Accrued Expenses	24.82	23.02	21.46	17.35	16.66	-
Short-Term Debt	-	-	135	-	-	-
Current Portion of Long-Term Debt	7.26	7.14	7.07	6.25	-	-
Current Portion of Leases	255.47	233.38	210.29	198.68	173.38	159.87
Current Income Taxes Payable	-	-	4.93	5.44	-	-
Current Unearned Revenue	10.32	8.23	7.44	10.87	12.5	14.48
Other Current Liabilities	122.45	142.25	118.9	144.27	130.02	127.07
Total Current Liabilities	920.73	921.39	1,045	900.34	776.11	592.75
Long-Term Debt	125.17	130.63	137.71	143.75	150	-
Long-Term Leases	846.61	870.13	826.51	708.58	567.47	497.09
Pension & Post-Retirement Benefits	5.79	5.79	3.93	4.38	7.93	8.73
Other Long-Term Liabilities	44.37	41.5	31.26	27.09	24.17	22.15
Total Liabilities	1,943	1,969	2,045	1,784	1,526	1,121
Common Stock	449.92	448.54	400	400	400	400
Additional Paid-In Capital	668.49	664.79	353.53	343.55	339.45	339.45
Retained Earnings	-44.14	1.19	62.82	48.14	-54.91	-93.92
Comprehensive Income & Other	1.88	1.65	-	-	-	-
Shareholders' Equity	1,076	1,116	816.35	791.69	684.54	645.52
Total Liabilities & Equity	3,019	3,086	2,861	2,576	2,210	1,766
Total Debt	1,235	1,241	1,317	1,057	890.85	656.96
Net Cash (Debt)	-956.08	-935.62	-1,156	-841	-687.49	-386.78
Net Cash Per Share	-21.27	-21.53	-27.36	-20.16	-17.19	-12.07
Filing Date Shares Outstanding	44.99	44.85	40	40	40	32.04
Total Common Shares Outstanding	44.99	44.85	40	40	40	32.04
Working Capital	513.34	543.24	246.44	254.29	218.81	345.77
Book Value Per Share	23.92	24.88	20.41	19.79	17.11	20.15
Tangible Book Value	1,072	1,109	812.48	786.72	675.16	635.37
Tangible Book Value Per Share	23.82	24.73	20.31	19.67	16.88	19.83
Land	217.03	217.03	217.03	217.03	217.03	3.19
Buildings	76.49	76.49	76.49	76.49	76.49	13.25
Machinery	30.44	30.02	27.62	29.14	21.67	9.66
Construction In Progress	3.62	0.68	4.4	2.49	3.5	1.41
Leasehold Improvements	400.93	387.76	345.44	304.32	232.24	199.14

Source: S&P Global Market Intelligence. Standard template. Financial Sources.